Mei-Wei Lin

Title: Innovations of Mei-Wei Lin

Introduction

Mei-Wei Lin is a prominent inventor based in Zhubei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of methods for screening host cells and therapeutic antibodies. With a total of 3 patents, his work has the potential to impact various medical applications.

Latest Patents

One of Mei-Wei Lin's latest patents is titled "Methods for screening host cells expressing target proteins." This patent describes a method that includes providing an expression vector containing a promoter, a gene encoding a target protein, and an FTH1 gene. The process involves transfecting host cells with the expression vector, culturing them in a medium, adding iron ions, and screening the surviving host cells to identify those expressing the target protein. Another significant patent is "Anti-TIGIT antibodies and methods of use," which discloses antibodies and antigen-binding fragments that bind to TIGIT. This patent also relates to methods and compositions for treating immune-related diseases, such as cancer and infections.

Career Highlights

Mei-Wei Lin is affiliated with the Industrial Technology Research Institute, where he continues to advance his research and innovations. His work is characterized by a strong focus on practical applications in biotechnology, aiming to address critical health challenges.

Collaborations

Mei-Wei Lin collaborates with notable colleagues, including Min-Yuan Chou and Yen-Ju Lin, who contribute to his research endeavors. Their combined expertise enhances the potential for groundbreaking discoveries in their field.

Conclusion

Mei-Wei Lin's innovative work in biotechnology, particularly in screening methods and therapeutic antibodies, showcases his commitment to advancing medical science. His contributions are poised to make a significant impact on the treatment of various diseases.